As patent disputes and concerns over drug price cuts have led to price corrections in biotech stocks, the need to reassess their technology value and earnings prospects has grown. Since their revenue models are tied to sales, investors should consider not only the extent of share price declines but also the impact of disputes and the outlook for future sales. As related uncertainties become clearer, identifying gaps between corporate value and stock prices can help investors explore opportunities to buy at lower levels.


If you are planning to buy shares of companies you are interested in through multiple purchases, you can review your available funds alongside the cost of your existing borrowings. One approach is to check the terms of stock-backed loans with annual interest rates in the 5% range, assess your investment capacity based on your account and eligible stocks, and consider refinancing to adjust financing costs if you are using credit or unsettled trades. By setting specific purchase amounts and funding plans based on business outlooks, you can respond more systematically to investment opportunities in a market correction.


HiStockLoan has maintained its position as the industry leader for 22 years and offers a variety of stock financing products, including products with annual interest rates in the 5% range. It can be used both to secure new investment funds and to refinance existing credit or unsettled trades at a lower cost. As a result, it is attracting attention as an option for investors seeking to improve the efficiency of their fund management while maintaining their investment opportunities.

Biotech Stocks Correct Amid Patent Disputes and Drug Price Cut Concerns: A Chance to Buy in Tranches? View original image

[Go to the industry-leading HiStockLoan: https://www.hisl.co.kr]


>> HiStockLoan: Get additional investment funds and refinance credit or unsettled trades at the industry's lowest annual interest rates in the 5% range!

HiStockLoan has launched a securities-linked credit product with annual interest rates in the 5% range, the industry's lowest, so that investors can use stock-backed loans without undue burden. The product can be used to buy stocks and to refinance unsettled trades or credit balances at securities firms. Investors can borrow up to four times their equity, including their own capital, regardless of their credit rating. Investors using alternative trading systems (NXT) can also use the product. Recently, securities firms have shortened the maturity of new credit loans from 180 days to 90 days, so investors concerned about the length of their funding period may also want to consider refinancing through a stock-backed loan.


Investors who would like to learn more about HiStockLoan's range of customized products can contact the customer service center at 1566-5113 for convenient consultations with a specialist 24 hours a day, whether or not they qualify for a loan.


○ Industry-lowest-rate product launched, with annual interest rates in the 5% range

○ ETF trading available

○ No. 1 in market share for 22 consecutive years; Korea First Brand Award winner for 17 consecutive years

○ Real-time repayment of unsettled trades and credit balances at securities firms

○ Trading through alternative trading systems (NXT) available

○ Reliable consultation quality guarantee system

* HiStockLoan Customer Service Center: 1566-5113

Go to: https://www.hisl.co.kr


Samsung Electronics Preferred, Daeduck Electronics, Celltrion, LIG Defense & Aerospace, Alteogen



※ This content does not reflect the editorial direction of The Asia Business Daily, and the information provider bears all responsibility.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing